Letter to Congress Opposing Draft Legislation That Would Expand Promotion of Medical Products for Unapproved Uses

July 11, 2017

View as PDF.

View Press Release.

Public Citizen sent a letter to members of Health Subcommittee of the U.S. House of Representatives’ Energy and Commerce Committee urging them to oppose draft legislation that would significantly expand marketing for unapproved uses of drugs and medical devices that have been approved or cleared by the FDA for at least one use. The legislation would undermine regulatory standards for ensuring that drugs and medical devices are safe and effective for each marketed use.

See Public Citizen’s other work on off-label use.